They found a total of 544 articles, but once duplicate articles were taken out, only 36 studies remained
However, reimbursement depends on medical necessity, documentation quality, payer policies, and NCCI edit compliance
Retatrutide is currently available as a research peptide while awaiting formal regulatory approval, offering an accessible alternative for those who want to explore the most advanced option before it reaches the pharmaceutical market
Tirzepatide shares the same contraindications as other GLP-1 medications it is not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, or with a history of pancreatitis
Muscle loss is not guaranteed and depends heavily on your exercise routine, protein intake, and genetics